Clorox (NYSE:CLX) Price Target Raised to $173.00 at JPMorgan Chase & Co.

Clorox (NYSE:CLX) had its price objective boosted by JPMorgan Chase & Co. from $171.00 to $173.00 in a research note released on Tuesday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock.

A number of other research analysts also recently commented on the company. Wells Fargo & Company upped their price objective on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday. DA Davidson upped their price target on shares of Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their price objective for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 price target on shares of Clorox in a research note on Thursday, January 30th. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, Clorox has an average rating of “Hold” and a consensus target price of $157.64.

Clorox Stock Down 7.2 %

CLX stock opened at $148.29 on Tuesday. The firm has a market cap of $18.36 billion, a price-to-earnings ratio of 51.67, a PEG ratio of 2.92 and a beta of 0.42. Clorox has a 1-year low of $127.60 and a 1-year high of $171.37. The firm has a fifty day moving average price of $162.63 and a two-hundred day moving average price of $158.67. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same quarter in the prior year, the firm posted $2.16 earnings per share. Research analysts predict that Clorox will post 6.86 EPS for the current year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.29%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is 170.04%.

Institutional Trading of Clorox

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Insight Folios Inc grew its position in Clorox by 3.0% in the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after buying an additional 63 shares during the last quarter. Integral Investment Advisors Inc. grew its holdings in shares of Clorox by 4.1% in the 4th quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after acquiring an additional 67 shares during the last quarter. HCR Wealth Advisors raised its position in shares of Clorox by 1.0% during the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after purchasing an additional 68 shares during the period. Empower Advisory Group LLC lifted its holdings in shares of Clorox by 4.5% during the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after purchasing an additional 78 shares during the last quarter. Finally, Aviance Capital Partners LLC boosted its position in shares of Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after purchasing an additional 80 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.